Literature DB >> 10884619

The role of probiotic bacteria in cancer prevention.

K Hirayama1, J Rafter.   

Abstract

Colorectal cancer is one of the most important causes of cancer morbidity and mortality in western countries [1]. A myriad of healthful effects have been attributed to the probiotic lactic acid bacteria; perhaps the most controversial remains that of anticancer activity. There is no direct experimental evidence for cancer suppression in humans as a result of consumption of lactic cultures in fermented or unfermented dairy products. However, there is a wealth of indirect evidence, based largely on laboratory studies, in the literature and this will be summarised in the present paper.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884619     DOI: 10.1016/s1286-4579(00)00357-9

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  43 in total

Review 1.  Probiotics and prebiotics in the elderly.

Authors:  J M T Hamilton-Miller
Journal:  Postgrad Med J       Date:  2004-08       Impact factor: 2.401

2.  Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures.

Authors:  Maddalena Rossi; Claudio Corradini; Alberto Amaretti; Marcello Nicolini; Anna Pompei; Simona Zanoni; Diego Matteuzzi
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

Review 3.  Intestinal microbiome and lymphoma development.

Authors:  Mitsuko L Yamamoto; Robert H Schiestl
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

4.  Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse.

Authors:  Akimitsu Takagi; Haruo Ikemura; Takeshi Matsuzaki; Mikiko Sato; Koji Nomoto; Masami Morotomi; Teruo Yokokura
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

5.  Practical identification of human originated Lactobacillus species by amplified ribosomal DNA restriction analysis (ARDRA) for probiotic use.

Authors:  Mehmet Öztürk; Merve Meterelliyöz
Journal:  Mol Biol Rep       Date:  2015-04-10       Impact factor: 2.316

6.  Genomic organization and molecular analysis of virulent bacteriophage 2972 infecting an exopolysaccharide-producing Streptococcus thermophilus strain.

Authors:  Céline Lévesque; Martin Duplessis; Jessica Labonté; Steve Labrie; Christophe Fremaux; Denise Tremblay; Sylvain Moineau
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

Review 7.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

8.  Proteomic comparison of the cytosolic proteins of three Bifidobacterium longum human isolates and B. longum NCC2705.

Authors:  Julio Aires; Patricia Anglade; Fabienne Baraige; Monique Zagorec; Marie-Christine Champomier-Vergès; Marie-José Butel
Journal:  BMC Microbiol       Date:  2010-01-29       Impact factor: 3.605

Review 9.  Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.

Authors:  Lay-Gaik Ooi; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2010-06-17       Impact factor: 5.923

10.  Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer.

Authors:  Marion Lenoir; Silvina Del Carmen; Naima G Cortes-Perez; Daniel Lozano-Ojalvo; Diego Muñoz-Provencio; Florian Chain; Philippe Langella; Alejandra de Moreno de LeBlanc; Jean Guy LeBlanc; Luis G Bermúdez-Humarán
Journal:  J Gastroenterol       Date:  2016-01-09       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.